SCHEMBL12474249

SCHEMBL12474249

PCCCC(C1CCCCC1)(C1CCCCC1)C1CCCCC1.PCCCC(C1CCCCC1)(C1CCCCC1)C1CCCCC1.[Pd]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14874308 0.89 SIGMAR1 (0.30)
Bromide SCHEMBL9388972 0.87
SCHEMBL27948056 0.77
SCHEMBL11519786 0.74 CYP1A2 (0.30)
SCHEMBL8577284 0.74 CYP1A2 (0.30)
SCHEMBL9073132 0.74 CYP1A2 (0.30)
SCHEMBL13892957 0.74 EPHX1 (0.35)
SCHEMBL8577287 0.74 CYP1A2 (0.30)
SCHEMBL11519789 0.74 CYP1A2 (0.30)
SCHEMBL9876981 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2675774-A1 PRODUCTION METHOD OF OPTICALLY ACTIVE DIHYDROBENZOFURAN DERIVATIVE Takeda Pharmaceutical Company Limited (JP) 2013-12-25 EP disclosed
WO-2012111849-A1 PRODUCTION METHOD OF OPTICALLY ACTIVE DIHYDROBENZOFURAN DERIVATIVE TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-08-23 WO disclosed